These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 10202282)
1. Serum level of a soluble receptor for interleukin-2 as a prognostic factor in patients with gastric cancer. Saito H; Tsujitani S; Ikeguchi M; Maeta M; Kaibara N Oncology; 1999 Apr; 56(3):253-8. PubMed ID: 10202282 [TBL] [Abstract][Full Text] [Related]
2. Serum-soluble interleukin-2 receptor concentrations in patients with gastric cancer. Murakami S; Satomi A; Ishida K; Murai H; Matsuki M; Hashimoto T Cancer; 1994 Nov; 74(10):2745-8. PubMed ID: 7525035 [TBL] [Abstract][Full Text] [Related]
4. Serum soluble interleukin-2 receptor as a predictor of lymph node metastasis in early gastric cancer. Murakami S; Sakata H; Tsuji Y; Okubo K; Hamada S; Hirayama R Dig Surg; 2002; 19(1):9-13; discussion 14. PubMed ID: 11961349 [TBL] [Abstract][Full Text] [Related]
5. Levels of serum-soluble receptor for interleukin-2 in patients with colorectal cancer. Saito H; Tsujitani S; Katano K; Ikeguchi M; Maeta M; Kaibara N Surg Today; 1998; 28(10):1115-7. PubMed ID: 9786595 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer. Kim JH; Jun KH; Jung H; Park IS; Chin HM Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088 [TBL] [Abstract][Full Text] [Related]
7. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus. Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976 [TBL] [Abstract][Full Text] [Related]
8. The clinical significance of serum soluble interleukin 2 receptor (sIL-2R) concentration in lung cancer. Naumnik W; Chyczewska E Folia Histochem Cytobiol; 2001; 39 Suppl 2():185-6. PubMed ID: 11820599 [TBL] [Abstract][Full Text] [Related]
9. Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens. Goto N; Tsurumi H; Goto H; Shimomura YI; Kasahara S; Hara T; Yasuda I; Shimizu M; Murakami N; Yoshikawa T; Fukuno K; Takahashi T; Kito Y; Takami T; Moriwaki H Ann Hematol; 2012 May; 91(5):705-714. PubMed ID: 22183251 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of preoperative and postoperative CK19 and CEA mRNA levels in peripheral blood of patients with gastric cardia cancer. Qiao YF; Chen CG; Yue J; Ma MQ; Ma Z; Yu ZT World J Gastroenterol; 2017 Feb; 23(8):1424-1433. PubMed ID: 28293089 [TBL] [Abstract][Full Text] [Related]
11. Serum-soluble interleukin-2 receptor (sIL-2R) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma: in combination with the International Prognostic Index. Goto H; Tsurumi H; Takemura M; Ino-Shimomura Y; Kasahara S; Sawada M; Yamada T; Hara T; Fukuno K; Goto N; Okuno M; Takami T; Seishima M; Moriwaki H J Cancer Res Clin Oncol; 2005 Feb; 131(2):73-9. PubMed ID: 15503137 [TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer. Hurteau JA; Woolas RP; Jacobs IJ; Oram DC; Kurman CC; Rubin LA; Nelson DL; Berchuck A; Bast RC; Mills GB Cancer; 1995 Nov; 76(9):1615-20. PubMed ID: 8635066 [TBL] [Abstract][Full Text] [Related]
13. High level of soluble interleukin-2 receptor in serum predicts treatment resistance and poor progression-free survival in multiple myeloma. Wang L; Wang JH; Liu WJ; Wang WD; Wang H; Chen XQ; Geng QR; Lu Y; Xia ZJ Ann Hematol; 2017 Dec; 96(12):2079-2088. PubMed ID: 28871325 [TBL] [Abstract][Full Text] [Related]
14. Increased serum concentration of circulating soluble receptor for interleukin-2 and its effect as a prognostic indicator in cachectic patients with gastric and colorectal cancer. Shibata M; Takekawa M Oncology; 1999; 56(1):54-8. PubMed ID: 9885378 [TBL] [Abstract][Full Text] [Related]
15. A progressive postoperative increase in the serum level of soluble receptors for interleukin-2 is an indicator of a poor prognosis in patients with gastric cancer. Maeta M; Saito H; Katano K; Kondo A; Tsujitani S; Makino M; Ikeguchi M; Kaibara N Int J Mol Med; 1998 Jan; 1(1):113-6. PubMed ID: 9852207 [TBL] [Abstract][Full Text] [Related]
16. Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma. Vonderheid EC; Zhang Q; Lessin SR; Polansky M; Abrams JT; Bigler RD; Wasik MA J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):207-20. PubMed ID: 9486676 [TBL] [Abstract][Full Text] [Related]
17. [Effect of early intestinal dripping of jianpi tongli Chinese herbs on serum level IL-2, sIL-2R and IL-12 in patients with gastric cancer after operation]. Yu QS; Liu Y; Hou Y; Zhang F; Yi W; Wang X; Shuai J Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Aug; 25(8):710-3. PubMed ID: 16152828 [TBL] [Abstract][Full Text] [Related]
18. Measurement of the concentration of serum soluble interleukin-2 receptor alpha chain in dogs with lymphoma. Mizutani N; Goto-Koshino Y; Kurata K; Fujiwara-Igarashi A; Sakaguchi M; Asada M; Ohno K; Tsujimoto H Vet Immunol Immunopathol; 2020 Jul; 225():110054. PubMed ID: 32434088 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of the soluble interleukin-2 receptor level after patients with follicular lymphoma achieve a response to R-CHOP. Umino K; Fujiwara SI; Ikeda T; Toda Y; Ito S; Mashima K; Minakata D; Nakano H; Yamasaki R; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y Hematology; 2017 Oct; 22(9):521-526. PubMed ID: 28413914 [TBL] [Abstract][Full Text] [Related]
20. Serum soluble vascular adhesion protein-1 is a valuable prognostic marker in gastric cancer. Yasuda H; Toiyama Y; Ohi M; Mohri Y; Miki C; Kusunoki M J Surg Oncol; 2011 Jun; 103(7):695-9. PubMed ID: 21308684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]